Abigail Williams-Adewole, Analyst at Lightning Health presents research at ISPOR Europe 2024 that explores the key challenges and opportunities for the evaluation of DMTs for the treatment of Alzheimer’s disease across a range of HTA authorities, and requirements to support reimbursed patient access.
Bhakti Dhingra, Senior Analyst at Lightning Health presents research at ISPOR Europe 2023 that explores the impact of four UK policies on evaluation of ATMPs in the UK
Nick Stringfellow, Senior Analyst at Lightning Health presents research at ISPOR Europe 2023 exploring HTA representative and payer perceptions of the proposed EU Pharmaceutical Legislation
Maddy Dawson and Nancy Cross, Consultants at Lightning Health present research at ISPOR Europe 2022 exploring the value of technology to deduce barriers to clinical trial diversity and facilitate the development of patient-centric medicine
Jake James, Senior Analyst at Lightning Health presents research at ISPOR Europe 2022 exploring the impact the EU-JCA will have throughout European healthcare systems (HTA93)
Our expert team will be at the meeting to present their recent research
Nancy Cross, Senior Analyst at Lightning Health presents a research poster at ISPOR Europe 2021 on payer awareness and perceptions of decentralised clinical trials. (POSB278)
Nasos Kipentzoglou presents new research at ISPOR Europe 2021 looking at the current processes for the evaluation of digital therapeutics (DTx), to ensure they meet the requirements of healthcare systems and ultimately, benefit patients. (POSB295)
Yasmina Zegaoui and Eleanor Butler present recent research at ISPOR Europe reviewing cross-country collaboration models with a focus on health technology assessment
Our expert team will present three posters of their recent work and thinking
Our expert team will be presenting three posters of our recent work and thinking
